|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2022―Sep―28 |
Genomic and evolutionary study from SARS-CoV-2 virus isolates from Bangladesh during the early stage of pandemic strongly correlate with European origin and not with China |
Mohammad Fazle Alam Rabbi, Mala Khan, Mamudul Hasan Razu, Md. Imran Khan, Saam Hasan, Mauricio Chalita, Kazi Nadim Hasan, Abu Sufian, Md. Bayejid Hosen, Mohammed Nafiz Imtiaz Polol, Jannatun Naima, Kihyun Lee, Yeong Ouk Kim, Md. Mizanur Rahman, Jongsik Chun, Md. Abdul Khaleque, Zabed Bin Ahmed, Nur A. Hasan, Rita R. Colwell, Sharif Akhteruzzaman |
2 |
[GO] |
2022―Aug―27 |
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength? |
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, Aparna Swaminathan, Nar Singh Chauhan, Rajesh Pandey |
3 |
[GO] |
2022―Jun―06 |
First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome |
Ramesh Pandit, Indra Singh, Afzal Ansari, Janvi Raval, Zarna Patel, Raghav Dixit, Pranay Shah, Kamlesh Upadhyay, Naresh Chauhan, Kairavi Desai, Meenakshi Shah, Bhavesh Modi, Madhvi Joshi, Chaitanya Joshi |
4 |
[GO] |
2021―Oct―28 |
Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy |
Erick Gustavo Dorlass, Karine Lima Lourenço, Rubens Daniel Miserani Magalhães, Hugo Sato, Alex Fiorini, Renata Peixoto, Helena Perez Coelho, Bruna Larotonda Telezynski, Guilherme Pereira Scagion, Tatiana Ometto, Luciano Matsumiya Thomazelli, Danielle Bruna Leal Oliveira, Ana Paula Fernandes, Edison Luiz Durigon, Flavio Guimarães Fonseca, Santuza Maria Ribeiro Teixeira |
5 |
[GO] |
2021―Aug―18 |
Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age |
Meng Wu, Lingwei Ma, Liru Xue, Qingqing Zhu, Su Zhou, Jun Dai, Wei Yan, Jinjin Zhang, Shixuan Wang |
6 |
[GO] |
2021―Jul―20 |
CoVrimer: A tool for aligning SARS-CoV-2 primer sequences and selection of conserved/degenerate primers |
Merve Vural, Aslinur Akturk, Mert Demirdizen, Ronaldo Leka, Rana Acar, Ozlen Konu |
7 |
[GO] |
2021―May―19 |
Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns |
Jayanta Kumar Das, Swarup Roy |
8 |
[GO] |
2021―May―15 |
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries |
Rui Wang, Jiahui Chen, Kaifu Gao, Guo-Wei Wei |
9 |
[GO] |
2021―Apr―08 |
ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections |
Luca Marcolungo, Cristina Beltrami, Chiara Degli Esposti, Giulia Lopatriello, Chiara Piubelli, Antonio Mori, Elena Pomari, Michela Deiana, Salvatore Scarso, Zeno Bisoffi, Valentina Grosso, Emanuela Cosentino, Simone Maestri, Denise Lavezzari, Barbara Iadarola, Marta Paterno, Elena Segala, Barbara Giovannone, Martina Gallinaro, Marzia Rossato, Massimo Delledonne |
10 |
[GO] |
2021―Apr―07 |
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality |
Jahad Alghamdi, Manal Alaamery, Tlili Barhoumi, Mamoon Rashid, Hala Alajmi, Nasser Aljasser, Yaseen Alhendi, Hend Alkhalaf, Hanadi Alqahtani, Omer Algablan, Abdulraham I. Alshaya, Nabiha Tashkandi, Salam Massadeh, Bader Almuzzaini, Salleh N. Ehaideb, Mohammad Bosaeed, Kamal Ayoub, Saber Yezli, Anas Khan, Ahmed Alaskar, Abderrezak Bouchama |
11 |
[GO] |
2021―Jan―20 |
Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID19 therapy |
Henry Sung-Ching Wong, Chin-Lin Guo, Gan-Hong Lin, Kang-Yun Lee, Yukinori Okada, Wei-Chiao Chang |
12 |
[GO] |
2020―Dec―28 |
Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing |
Pingping Wang, Xiyun Jin, Wenyang Zhou, Meng Luo, Zhaochun Xu, Chang Xu, Yiqun Li, Kexin Ma, Huimin Cao, Yan Huang, Guangfu Xue, Shuilin Jin, Huan Nie, Qinghua Jiang |
13 |
[GO] |
2020―Dec―13 |
A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2 |
Umar Faruq Chowdhury, Mohammad Umer Sharif Shohan, Kazi Injamamul Hoque, Mirza Ashikul Beg, Mohammad Kawsar Sharif Siam, Mohammad Ali Moni |
14 |
[GO] |
2020―Nov―13 |
Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19 |
Gourab Das, Troyee Das, Nilkanta Chowdhury, Durbadal Chatterjee, Angshuman Bagchi, Zhumur Ghosh |
15 |
[GO] |
2020―Nov―05 |
Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus |
Chayan Roy, Santi M. Mandal, Suresh K. Mondal, Shriparna Mukherjee, Tarunendu Mapder, Wriddhiman Ghosh, Ranadhir Chakraborty |
16 |
[GO] |
2020―Oct―20 |
Variant analysis of the first Lebanese SARS-CoV-2 isolates |
Mhamad Abou-Hamdan, Kassem Hamze, Ali Abdel Sater, Haidar Akl, Nabil El-zein, Israa Dandache, Fadi Abdel-sater |
17 |
[GO] |
2020―Sep―30 |
Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection |
Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour |
18 |
[GO] |
2020―Sep―20 |
Mutations on COVID-19 diagnostic targets |
Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei |
19 |
[GO] |
2020―Sep―12 |
Molecular phylogeny and missense mutations of envelope proteins across coronaviruses |
Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy |
20 |
[GO] |
2020―Sep―10 |
SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design |
Sandeep Kumar Kushwaha, Veerbhan Kesarwani, Samraggi Choudhury, Sonu Gandhi, Shailesh Sharma |
21 |
[GO] |
2020―Sep―08 |
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis |
Abdus Samad, Tamanna Jafar, Jahirul Hasnat Rafi |
22 |
[GO] |
2020―Aug―19 |
Missense mutations in SARS-CoV2 genomes from Indian patients |
Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy, Siddhartha Sankar Jana |
23 |
[GO] |
2020―Aug―07 |
Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach |
Pandiyan Muthuramalingam, Rajendran Jeyasri, Alaguvel Valliammai, Anthonymuthu Selvaraj, Chandrasekar Karthika, Shanmugaraj Gowrishankar, Shunmugiah Karutha Pandian, Manikandan Ramesh, Jen-Tsung Chen |
24 |
[GO] |
2020―Jul―31 |
Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method |
Liqian Zhou, Juanjuan Wang, Guangyi Liu, Qingqing Lu, Ruyi Dong, Geng Tian, Jialiang Yang, Lihong Peng |
25 |
[GO] |
2020―Jul―25 |
Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2 |
Namisha Sharma, Mehanathan Muthamilarasan, Ashish Prasad, Manoj Prasad |
26 |
[GO] |
2020―Jul―06 |
Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses |
Rabeb Touati, Sondes Haddad-Boubaker, Imen Ferchichi, Imen Messaoudi, Afef Elloumi Ouesleti, Henda Triki, Zied Lachiri, Maher Kharrat |
27 |
[GO] |
2020―Jul―05 |
SARS-CoV2 envelope protein: non-synonymous mutations and its consequences |
Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy |
28 |
[GO] |
2020―Jun―12 |
Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes |
Sk. Sarif Hassan, Pabitra Pal Choudhury, Pallab Basu, Siddhartha Sankar Jana |
29 |
[GO] |
2020―Apr―27 |
Genotyping coronavirus SARS-CoV-2: methods and implications |
Changchuan Yin |